Meeting report: Regulatory myeloid cells

International Immunopharmacology

Volumn 11, Issue 7, 2011, Pages 780-782

  LaFace, Drake ^a   Talmadge, James ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

cancer; chemokines; cytokines; MDSC; Regulatory Myeloid Cells; suppression

Indexed keywords

IMMUNOMODULATING AGENT; SILDENAFIL; SUNITINIB;

AUTOIMMUNITY; BONE MARROW CELL; CANCER PATIENT; CHRONIC INFLAMMATION; CONFERENCE PAPER; DISEASE ASSOCIATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY CARCINOMA; PATHOLOGY; PRIORITY JOURNAL; SUPPRESSOR CELL;

ANIMALS; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; HUMANS; IMMUNOMODULATION; IMMUNOTHERAPY; INFECTION; INFLAMMATION; MICE; MYELOID CELLS; NEOPLASMS;

EID: 79958076315     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.01.031     Document Type: Conference Paper

References (10)

1. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889;133:571-3.
2. Marigo I, Bosio E, Solito S, Mesa C, Fernandez A, Dolcetti L, et al. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 2010;32:790-802.
3. Kerkar SP, Muranski P, Kaiser A, Boni A, Sanchez-Perez L, Yu Z, et al. Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts. Cancer 2010;70:6725-34.
4. Jales A, Falahati R, Mari E, Stemmy EJ, Shen W, Southammakosane C, et al. Ganglioside-exposed dendritic cells inhibit T-cell effector function by promoting regulatory cell activity. Immunology 2011;132:134-43.
5. Rodriguez PC, Hernandez CP, Morrow K, Sierra R, Zabaleta J, Wyczechowska DD, et al. L-arginine deprivation regulates cyclin D3 mRNA stability in human T cells by controlling HuR expression. J 2010;185:5198-204.
6. Srivastava MK, Sinha P, Clements VK, Rodriguez P, Ostrand-Rosenberg S. Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res 2009;70:68-77.
7. Youn JI, Gabrilovich DI. The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur J Immunol 2010;40:2969-75.
8. Pande K, Ueda R, Machemer T, Sathe M, Tsai V, Brin E, et al. Cancer-induced expansion and activation of CD11b+ Gr-1+ cells predispose mice to adenoviral-triggered anaphylactoid-type reactions. Mol Ther 2009;17:508-15.
9. Ko JS, Zea AH, Rini BI, Ireland JL, Elson P, Cohen P, et al. Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients. Clin Cancer Res 2009;15:2148-57.
10. Serafini P, Meckel K, Kelso M, Noonan K, Califano J, Koch W, et al. Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function. J Exp Med 2006;203:2691-702. (Pubitemid 44833345)